What is the ticker symbol for Vincerx Pharma?

Vincerx Pharma trades under the ticker VINCU on NASDAQ.

What sector does Vincerx Pharma operate in?

Vincerx Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VINCU in a portfolio?

PortView shows VINCU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Vincerx Pharma (VINCU) Stock Analysis

NASDAQHealthcareBiotechnology

$27.00+0.00%

52-week range$27.00

$19.26$31.00

What Vincerx Pharma does

Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing novel therapeutic solutions for cancer patients in the United States, aiming to address critical unmet medical needs. The company's leading investigational compound, VIP152, is a cyclin-dependent kinase-9 (CDK9) inhibitor specifically formulated to treat individuals diagnosed with advanced forms of cancer. Its early-stage development pipeline additionally features several promising candidates: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate designed to target solid tumors; and VIP943 and VIP924, both of which are being explored for their potential in combating hematologic malignancies. Vincerx Pharma, Inc. was established in 2019 and operates from its corporate headquarters situated in Palo Alto, California.

Key metrics

Market cap

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

1.27

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$27.78

200-day avg

$27.85

52-week high

$31.00

52-week low

$19.26

ETFs linked to VINCU

Broad-market and Healthcare sector ETFs an investor holding Vincerx Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VINCU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VINCU in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Vincerx Pharma?: Vincerx Pharma trades under the ticker VINCU on NASDAQ.
Which exchange is VINCU listed on?: VINCU is listed on NASDAQ.
What sector does Vincerx Pharma operate in?: Vincerx Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VINCU in a portfolio?: PortView shows VINCU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.